Microsoft-led researchers have discovered a "biological zero-day" vulnerability in DNA sequence screening systems, potentially allowing AI-designed toxins to bypass detection. The team found that AI can create protein variants sufficiently different from known threats to evade current biosurveillance software. While some screening tools have been updated, the researchers emphasize the need for ongoing vigilance as AI protein design capabilities advance.

Prepared by Olivia Bennett and reviewed by editorial team.